Superstring Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
+2,099
New +$1.11M 0.53% 29
2025
Q2
– Sell
-3,815
Closed -$1.26M – 41
2025
Q1
$1.26M Buy
3,815
+2,686
+238% +$883K 1.5% 20
2024
Q4
$348K Buy
+1,129
New +$318K 0.3% 36

Other funds holding MDGL

Superstring Capital Management's MDGL Position: Q3 2026 in Review

Superstring Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 2,099 shares worth $1.06M. The stake represents 0.53% of the portfolio and ranks #29 among its holdings. This is a return to the name: Superstring Capital Management previously reported a position in MDGL as recently as Q1 2025.

Superstring Capital Management first reported a position in MDGL in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.26M in Q1 2025. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Superstring Capital Management held 2,099 shares of Madrigal Pharmaceuticals worth $1.06M as of Q3 2026.
  • Madrigal Pharmaceuticals was a new Superstring Capital Management position in Q3 2026.
  • Madrigal Pharmaceuticals made up 0.53% of Superstring Capital Management's portfolio in Q3 2026, its #29 holding.
  • Superstring Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Superstring Capital Management's Madrigal Pharmaceuticals position peaked at $1.26M in Q1 2025.
  • 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Superstring Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.